QA: XOMA Corp in us_pharma/2020

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000791908_2021_XOMA_Corp.pdf

Logs

info Ambiguous roles for statement input.sec.calculation_linkbase.expand_agg {'statement': 'operations', 'valid_roles': {'00200 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE (LOSS) INCOME (unaudited) (calc 2)': 2, '00200 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)': 11}}
info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0000791908, XOMA Corp

  xvar xval
0 AssetsCurrent 88,065,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 21,000
3 remainder_Assets 37,199,000
4 LiabilitiesCurrent 12,302,000
5 LiabilitiesNoncurrent 13,043,000
6 remainder_Liabilities 13,516,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 16,799,000
9 ResearchAndDevelopmentExpense 170,000
10 remainder_Expenses 343,000
11 remainder_Revenues 29,385,000
12 remainder_NetIncome 1,225,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 125,285,000
1 Liabilities 38,861,000
2 Expenses 17,312,000
3 Revenues 29,385,000
4 StockholdersEquity 86,424,000
5 NetIncome 13,298,000
6 ComprehensiveNetIncome 13,298,000
7 BaseVar 106,034,000
8 EconomicCapitalRatio 1.97

Edgar->Model Mapping

Feature Distribution

Change over Time